Ascendiant Capital Maintains Buy on Aemetis, Raises Price Target to $21
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and raises the price target from $20 to $21.
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and raises the price target from $20 to $21.